Key facts
- Xaga Surgical’s last known valuation is $4.5M (Jan 2025).
- It has raised $2.4M; the latest was Later Stage VC ($720K) in Jan 2025.
- Notable investors include Almi Invest, EIT Health, SmiLe Incubator.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Xaga Surgical
- ·The full record, as it builds
Funding rounds
No funding rounds for Xaga Surgical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Xaga Surgical
Developer of medical needles designed to minimize the risk of infections. The company's needle reduces the risk of severe sepsis by virtually eliminating bacterial transfer upon insertion and increases safety during the diagnosis of prostate cancer and other diseases, enabling patients to reduce the risk of getting a severe infection and the healthcare industry to prioritize patient safety.
- Sector
- Healthcare
- HQ
- Eslöv, Sweden
- Founded
- 2016
- Employees
- 6
- Website
- xagasurgical.com/
- Ownership
- Privately Held (backing)
Xaga Surgical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Xaga Surgical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Xaga Surgical in its N-PORT filings yet. We sweep new filings monthly.